Rahman Ali, Akbulut Handan, Bayar Mustafa Kemal, Ozden Mehmet, Burma Oktay, Uysal Ayhan
Department of Cardiovascular Surgery, Faculty of Medicine, Firat University, Elaziğ, Turkey.
Anadolu Kardiyol Derg. 2009 Aug;9(4):318-24.
Cardiopulmonary bypass (CPB) leads to systemic inflammatory response syndrome (SIRS). In vitro studies showed that amiodarone blocked cytokine production. The aim of this study was to evaluate the effect of intra-operative amiodarone loading on SIRS.
This prospective randomized study included 24 patients who underwent on-pump coronary artery surgery. The patients were classified into control (n=12) and amiodarone (n=12) groups. Plasma levels of the pro-inflammatory (C-reactive protein - CRP, interleukin-6 - IL-6) and the anti-inflammatory markers (interleukin-10 - IL-10) were measured before the induction of anesthesia, 5 minutes after aortic declamping, after protamine administration and 24 hours after the CPB. The myocardial lactate production was calculated before CPB and 5 minutes after aortic declamping. Statistical analyses were performed using Mann-Whitney U, Fischer's exact and ANOVA tests.
In both groups, the IL-6 levels significantly increased after declamping (91.18+/-16.27 pg/ml and 86.37+/-14.66 pg/ml, p<0.01) and reached peak values after infusion of protamine (329.07+/-32.24 pg/ml and 354.31+/-29.61 pg/ml, p<0.01). The highest values of IL-10 were detected after infusion of protamine in the control and amiodarone groups (265.58+/-85.63 pg/ml, p<0.01 and 287.44+/-65.26 pg/ml, p<0.01). Amiodarone did not have any significant effect on release of cytokines. The CRP levels were significantly elevated in both groups at 24th hour after CPB, but no significant difference was found between the groups. Compared with pre-CPB values, lactate production increased significantly in two groups after aortic declamping. However there was no significant difference between the groups.
The results indicate that intraoperative loading of amiodarone, which is used for atrial fibrillation prophylaxis, does not seem to alter inflammatory response during CPB.
体外循环(CPB)可导致全身炎症反应综合征(SIRS)。体外研究表明,胺碘酮可阻止细胞因子的产生。本研究的目的是评估术中负荷剂量胺碘酮对SIRS的影响。
这项前瞻性随机研究纳入了24例行体外循环冠状动脉手术的患者。患者被分为对照组(n = 12)和胺碘酮组(n = 12)。在麻醉诱导前、主动脉开放夹闭后5分钟、鱼精蛋白给药后以及体外循环后24小时,测量促炎标志物(C反应蛋白 - CRP、白细胞介素 - 6 - IL - 6)和抗炎标志物(白细胞介素 - 10 - IL - 10)的血浆水平。计算体外循环前和主动脉开放夹闭后5分钟的心肌乳酸生成量。使用曼 - 惠特尼U检验、费舍尔精确检验和方差分析进行统计分析。
两组患者在主动脉开放夹闭后IL - 6水平均显著升高(分别为91.18±16.27 pg/ml和86.37±14.66 pg/ml,p<0.01),并在输注鱼精蛋白后达到峰值(分别为329.07±32.24 pg/ml和354.З1±29.61 pg/ml,p<0.01)。在对照组和胺碘酮组中,输注鱼精蛋白后检测到IL - 10的最高值(分别为265.58±85.63 pg/ml,p<0.01和287.44±65.26 pg/ml,p<0.01)。胺碘酮对细胞因子的释放没有任何显著影响。两组患者在体外循环后第24小时CRP水平均显著升高,但两组之间无显著差异。与体外循环前的值相比,两组在主动脉开放夹闭后乳酸生成量均显著增加。然而,两组之间无显著差异。
结果表明,用于预防房颤的术中负荷剂量胺碘酮似乎不会改变体外循环期间的炎症反应。